Henry Ward Wolff - Net Worth and Insider Trading
Henry Ward Wolff Net Worth
The estimated net worth of Henry Ward Wolff is at least $535,244 dollars as of 2024-11-13. Henry Ward Wolff is the Exec VP & CFO of Sangamo Therapeutics Inc and owns about 197,872 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $535,244. Henry Ward Wolff is also the Director of Portola Pharmaceuticals Inc and owns about 0 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $0. Details can be seen in Henry Ward Wolff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Henry Ward Wolff has not made any transactions after 2017-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Henry Ward Wolff
Henry Ward Wolff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Henry Ward Wolff owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Sunesis Pharmaceuticals Inc (SNSS) , and Calithera Biosciences Inc (CALA) among others .
Click here to see the complete history of Henry Ward Wolff’s form 4 insider trades.
Insider Ownership Summary of Henry Ward Wolff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
| SNSS | Sunesis Pharmaceuticals Inc | 2020-06-30 | director |
| CALA | Calithera Biosciences Inc | 2016-06-14 | director |
 | | 2015-07-13 | Exec VP & CFO |
| | 2006-07-24 | Sr. VP Finance and CFO |
| | 2019-06-28 | director |
Henry Ward Wolff Latest Holdings Summary
Henry Ward Wolff currently owns a total of 2 stocks. Among these stocks, Henry Ward Wolff owns 197,872 shares of Sangamo Therapeutics Inc (SGMO) as of July 13, 2015, with a value of $535,244 and a weighting of 100%. Henry Ward Wolff also owns 0 shares of Portola Pharmaceuticals Inc (PTLA) as of December 15, 2017, with a value of $0 and a weighting of 0%.
Latest Holdings of Henry Ward Wolff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2015-07-13 | 197,872 | 2.71 | 535,244 |
| PTLA | Portola Pharmaceuticals Inc | 2017-12-15 | 0 | 18.03 | 0 |
Holding Weightings of Henry Ward Wolff
Henry Ward Wolff Form 4 Trading Tracker
According to the SEC Form 4 filings, Henry Ward Wolff has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 12,000 shares on July 13, 2015, which brought Henry Ward Wolff around $120,000.
According to the SEC Form 4 filings, Henry Ward Wolff has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 12,000 shares on December 15, 2017, which brought Henry Ward Wolff around $564,000.
Insider Trading History of Henry Ward Wolff
- 1
Henry Ward Wolff Trading Performance
GuruFocus tracks the stock performance after each of Henry Ward Wolff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry Ward Wolff is 57.43%. GuruFocus also compares Henry Ward Wolff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry Ward Wolff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Henry Ward Wolff's insider trading performs compared to the benchmark.
Performance of Henry Ward Wolff
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.88 | | | | | |
| Relative Return to S&P 500(%) | 7.08 | | | | | |
Henry Ward Wolff Ownership Network
Ownership Network List of Henry Ward Wolff
Ownership Network Relation of Henry Ward Wolff
Henry Ward Wolff Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Henry Ward Wolff is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Henry Ward Wolff Mailing Address
Above is the net worth, insider trading, and ownership report for Henry Ward Wolff. You might contact Henry Ward Wolff via mailing address: 6701 Kaiser Drive, Fremont Ca 94555.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
